Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

SELL
$25.26 - $29.6 $96,594 - $113,190
-3,824 Reduced 3.82%
96,339 $2.7 Million
Q1 2024

Apr 15, 2024

BUY
$25.89 - $29.73 $696,207 - $799,469
26,891 Added 36.7%
100,163 $2.78 Million
Q4 2023

Jan 26, 2024

BUY
$26.13 - $33.94 $35,850 - $46,565
1,372 Added 1.91%
73,272 $2.11 Million
Q3 2023

Oct 12, 2023

SELL
$32.09 - $37.51 $7,926 - $9,264
-247 Reduced 0.34%
71,900 $2.38 Million
Q2 2023

Jul 26, 2023

BUY
$36.12 - $41.79 $2.61 Million - $3.02 Million
72,147 New
72,147 $2.65 Million
Q2 2021

Jul 22, 2021

SELL
$35.91 - $40.68 $1.07 Million - $1.21 Million
-29,680 Closed
0 $0
Q1 2021

Apr 15, 2021

BUY
$33.49 - $37.77 $43,537 - $49,101
1,300 Added 4.58%
29,680 $1.08 Million
Q4 2020

Jan 21, 2021

BUY
$33.47 - $42.56 $11,379 - $14,470
340 Added 1.21%
28,380 $1.05 Million
Q3 2020

Oct 21, 2020

BUY
$31.75 - $37.25 $68,230 - $80,050
2,149 Added 8.3%
28,040 $1.03 Million
Q2 2020

Jul 24, 2020

BUY
$30.12 - $36.54 $57,468 - $69,718
1,908 Added 7.96%
25,891 $847,000
Q1 2020

Apr 23, 2020

SELL
$27.03 - $38.62 $1,216 - $1,737
-45 Reduced 0.19%
23,983 $782,000
Q4 2019

Jan 21, 2020

SELL
$32.92 - $37.36 $6,584 - $7,472
-200 Reduced 0.83%
24,028 $941,000
Q3 2019

Oct 17, 2019

SELL
$32.49 - $42.13 $38,988 - $50,556
-1,200 Reduced 4.72%
24,228 $871,000
Q2 2019

Jul 19, 2019

BUY
$36.98 - $41.52 $15,716 - $17,646
425 Added 1.7%
25,428 $1.1 Million
Q1 2019

Apr 22, 2019

BUY
$37.5 - $41.2 $97,687 - $107,326
2,605 Added 11.63%
25,003 $1.06 Million
Q4 2018

Jan 15, 2019

BUY
$38.47 - $43.86 $90,327 - $102,983
2,348 Added 11.71%
22,398 $978,000
Q2 2018

Aug 01, 2018

BUY
$32.98 - $35.16 $138,516 - $147,672
4,200 Added 26.5%
20,050 $727,000
Q1 2018

Apr 25, 2018

BUY
$31.91 - $37.02 $35,101 - $40,722
1,100 Added 7.46%
15,850 $563,000
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $490,584 - $520,527
14,750
14,750 $534,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track G&S Capital LLC Portfolio

Follow G&S Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of G&S Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on G&S Capital LLC with notifications on news.